Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872833 · ClinicalTrials.gov registry record
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 32
- Enrollment target
NCT00872833: Completed study, sponsored by Carelon Research.
NCT00872833 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00872833 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.
Primary Outcome
Subjects reported whether or not they had pain (yes/no) during each transfusion cycle (data on up to 3 transfusion cycles were collected for each subject). The percent of subject-cycles with pain was calculated for the quartiles of the transfusion cycle.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-10 |
What the finished NCT00872833 record still lists
NCT00872833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00872833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00872833 about?
NCT00872833 is a clinical study titled "Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions". Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study...
What is the current status of trial NCT00872833?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2009-07. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00872833?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia